Robust Fuzzy Sliding Mode Controller Design for a Multiple Sclerosis Model
暂无分享,去创建一个
Ramin Vatankhah | Sajjad Taghvaei | Mohammad Eghtesad | Elnaz Kohanpour | R. Vatankhah | M. Eghtesad | S. Taghvaei | Elnaz Kohanpour
[1] Wolfgang Brück,et al. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage , 2005, Journal of Neurology.
[2] Manuel A. Friese,et al. Immunopathology of multiple sclerosis , 2015, Nature Reviews Immunology.
[3] Clare Baecher-Allan,et al. Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.
[4] Manuel A. Friese,et al. Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis , 2014, Nature Reviews Neurology.
[5] Narsis A Kiani,et al. A minimal unified model of disease trajectories captures hallmarks of multiple sclerosis. , 2017, Mathematical biosciences.
[6] M. Toda,et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.
[7] J K Udupa,et al. Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. , 2000, Radiology.
[8] Illés J. Farkas,et al. SignaLink 2 – a signaling pathway resource with multi-layered regulatory networks , 2013, BMC Systems Biology.
[9] Ariel Miller,et al. Revised diagnostic criteria of multiple sclerosis. , 2014, Autoimmunity reviews.
[10] D. Chari,et al. Remyelination In Multiple Sclerosis , 2007, International Review of Neurobiology.
[11] Pablo Villoslada,et al. Dynamic cross-regulation of antigen-specific effector and regulatory T cell subpopulations and microglia in brain autoimmunity , 2013, BMC Systems Biology.